Location History:
- Montrouge, FR (2018 - 2019)
- Le Grand Lemps, FR (2021)
Company Filing History:
Years Active: 2018-2021
Title: Innovations of Julien Bouley in Immunotherapy
Introduction
Julien Bouley is a notable inventor based in Montrouge, France. He has made significant contributions to the field of immunotherapy, particularly through his innovative research and patents. With a total of 4 patents, Bouley has focused on identifying markers and methods that enhance the efficacy of immunotherapy.
Latest Patents
One of his latest patents is titled "Sialylated fetuin-A as a marker of immunotherapy efficacy." This invention concerns the identification of specific polypeptides and their variants, which can serve as markers for predicting a patient's responsiveness to immunotherapy. Another significant patent involves "Methods for identifying dendritic cell subsets." This invention outlines methods for determining whether a dendritic cell belongs to a tolerogenic or effector subset, as well as assessing a patient's immune response during immunotherapy.
Career Highlights
Julien Bouley is currently associated with Stallergenes, a company known for its work in immunotherapy and allergy treatments. His role at Stallergenes allows him to apply his innovative ideas in a practical setting, contributing to advancements in patient care.
Collaborations
Throughout his career, Bouley has collaborated with esteemed colleagues such as Philippe Moingeon and Emmanuel Nony. These collaborations have further enriched his research and development efforts in the field of immunotherapy.
Conclusion
Julien Bouley's work exemplifies the intersection of innovation and healthcare, particularly in the realm of immunotherapy. His patents and ongoing research continue to pave the way for improved treatment options for patients.